Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 16Stomach Neoplasms 13Lung Neoplasms 9Adenocarcinoma 5Neoplasms 4Neoplasm Metastasis 4Esophageal Neoplasms 4Adenocarcinoma Of Esophagus 3Squamous Cell Carcinoma of Head and Neck 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Urinary Bladder Neoplasms 1Thymoma 1Solid Tumors 1Solid Cancer 1Sarcoma 1Recurrence 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Neoplasms 1Neoplasms by Site 1Metastatic Small Intestinal Adenocarcinoma 1Metastatic Gastric Adenocarcinoma 1Melanoma 1Lymphoma, Non-Hodgkin 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Fallopian Tube Neoplasms 1Digestive System Neoplasms 1Desmoplastic Small Round Cell Tumor 1Clinical Stage IVB Gastric Cancer AJCC v8 1

Interventions

Temozolomide 3Cyclophosphamide 3fludarabine phosphate 2Vincristine 2PM 01183 2Irinotecan 2Ifosfamide 2Etoposide 2Doxorubicin 2thymoglobulin 1temsirolimus 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1fludarabine 1Zoledronic Acid 1Vinorelbine 1Thiotepa 1Tacrolimus 1Surgical Procedures, Operative 1Stem Cell Transplantation 1Sorafenib 1Ramucirumab 1Radiotherapy, Intensity-Modulated 1Radiation 1Proton Therapy 1Mycophenolic Acid 1Mesna 1Melphalan 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Desmoplastic Small Round Cell Tumor × Ramucirumab × 1 year × Clear all
NCT04145349 2026-05-11

CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor

Eli Lilly and Company

Phase 1/2 Completed
30 enrolled 16 charts
Sarcoma

Sarcoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡